Frank is in Congress to lower the price of healthcare and to make prescription drug prices more affordable, so families can obtain the lifesaving medicine they need.
Lower healthcare costs and make prescription drugs more affordable.
Occurrences
he is pleased that these provisions will provide increased certainty and financial stability for these critical health care providers
Evidence
Mrvan announced that health provisions in H.R. 5064, the Save our Safety-Net Hospitals Act, were included in an appropriations measure signed into law. The release says the provisions delay certain Medicaid DSH reductions until FY2028 and change the Medicaid shortfall definition.
Mrvan voted to approve a three-year extension of Affordable Care Act subsidies 'to protect healthcare access for Northwest Indiana residents.' The page says the extension would reduce premium burden for constituents facing sharply higher 2026 costs.
Mrvan said health provisions from H.R. 5064 were included in a signed appropriations measure, delaying certain Medicaid DSH reductions until FY2028 and changing the Medicaid shortfall definition.
The House passed a three-year extension of ACA subsidies, and Mrvan said he voted yes to protect healthcare access for Northwest Indiana residents because premiums for 2026 were uncertain and rising.
Assessments
Mrvan has same-term evidence of materially advancing narrower healthcare-cost measures: health provisions from his H.R. 5064 were incorporated into a signed appropriations law, delaying Medicaid DSH cuts and helping preserve safety-net hospital funding, and he also voted for an ACA subsidy extension intended to reduce premium burdens. But the promise was broader, explicitly covering both healthcare costs and prescription-drug affordability. The provided evidence does not show a clear enacted prescription-drug affordability result attributable to him, nor a broad fulfillment of the full promise. Under federal legislative credit, these actions support meaningful but incomplete delivery.
Mrvan took same-term federal action aligned with lowering healthcare costs, including advancing health provisions that were signed into law to delay Medicaid DSH reductions and supporting House passage of an ACA subsidy extension. These actions plausibly help preserve access and reduce some healthcare cost burdens. However, the evidence does not show full delivery of the broader promise, especially making prescription drugs more affordable, and the ACA subsidy item is a House-passed measure rather than a fully enacted broad outcome. Credit is therefore partial rather than delivered.